In addition, BUD31 was positively correlated with plenty of inclusion events, including BCL2L12 AS, in ovarian cancer based on PSI value profiles in the TCGA-Spliceseq database (Fig. 6m). This evidence concerns the gene BUD31 and ovarian cancer.